🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center center phase I/II study to establish the lowest possible ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-06-05
Trial ID
NCT05123040
Treatments Being Tested
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
To determine the safety of the approach of giving RUXOLITINIB before and af...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02469974
Treatments Being Tested
This study is a prospective, open-label, multi-center, non-comparative, obs...
Status
Completed
Location
Novartis Investigative Site
Start Date
2023-04-07
Trial ID
NCT05621733
Treatments Being Tested
The primary objective of this study is to evaluate the safety, tolerability...
Status
Terminated
Location
Stanford Hospital and Clinics
Start Date
2015-06-05
Trial ID
NCT02436135
Treatments Being Tested
This is a phase Ib study with the primary purpose is to estimate the MTD an...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-21
Trial ID
NCT02370706
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02119676
Treatments Being Tested
The participants are being asked to take part in this clinical trial becaus...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2023-03-14
Trial ID
NCT05579769
This was a randomized, double-blind, placebo-controlled phase 2 clinical tr...
Status
Terminated
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02120417
Treatments Being Tested
In this open-label single arm phase 2 study, approximately 20 patients with...
Status
Recruiting
Location
Department of Medicine, Queen Mary Hospital
Start Date
2025-03-01
Trial ID
NCT06770842
Treatments Being Tested